Mylan NV (MYL)

MYL (NASDAQ:Drugs) EQUITY
$72.17
pos +0.13
+0.18%
Today's Range: 72.17 - 72.79 | MYL Avg Daily Volume: 9,560,700
Last Update: 05/28/15 - 10:07 AM EDT
Volume: 578,525
YTD Performance: 27.80%
Open: $72.50
Previous Close: $72.04
52 Week Range: $44.80 - $76.69
Oustanding Shares: 490,033,276
Market Cap: 34,571,847,622
6-Month Chart
TheStreet Ratings Grade for MYL
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 9 10 10
Moderate Buy 0 0 1 0
Hold 2 2 1 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.44 1.36 1.21 1.33
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 32.36
Price Earnings Comparisons:
MYL Sector Avg. S&P 500
32.36 32.50 26.72
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
25.67% 48.78% 233.06%
GROWTH 12 Mo 3 Yr CAGR
Revenue 11.70 0.26 0.08
Net Income 48.90 0.73 0.20
EPS 47.70 0.99 0.26
Earnings for MYL:
EBITDA 1.89B
Revenue 7.72B
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (12/15) FY (12/16)
Average Estimate $0.92 $1.19 $4.13 $4.64
Number of Analysts 2 1 5 5
High Estimate $0.95 $1.19 $4.25 $4.83
Low Estimate $0.88 $1.19 $4.07 $4.37
Prior Year $0.69 $1.16 $3.56 $4.13
Growth Rate (Year over Year) 32.61% 2.59% 16.07% 12.20%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Dan Fitzpatrick

 | May 27, 2015 | 5:00 PM EDT

Sector may not be as bulletproof as we thought.

By

Jim Cramer

 | May 27, 2015 | 3:55 PM EDT

Jim Cramer answers your Twitter questions about FireEye (FEYE) and other stocks from the floor of the New York Stock Exchange.

By

Jim Cramer

 | May 21, 2015 | 6:49 PM EDT

Deals coming fast and furious in the best group in town.

By

Jim Cramer

 | May 18, 2015 | 3:24 PM EDT

Acquisitions cut into overabundance of companies.

By

Antonia Oprita

 | Apr 22, 2015 | 5:30 AM EDT

And four other things you need to know now.

By

David Peltier

 | Apr 21, 2015 | 4:49 PM EDT

U.S. stocks were mixed on Tuesday.

By

Jim Cramer

 | Apr 21, 2015 | 3:44 PM EDT

Biotech companies are saying, "I do."

By

David Katz

 | Apr 21, 2015 | 1:05 PM EDT

Teva bid highlights M&A action in health care sector.

By

David Katz

 | Apr 21, 2015 | 12:53 PM EDT

Teva bid highlights M&A action in health care sector.

By

Jim Cramer

 | Apr 9, 2015 | 1:58 PM EDT

These companies are the hottest thing going.

In a small way at $212.42.
Back slightly net short now.

I reestablished a small QQQ short at $110.82.

The Avago/Broadcom deal is another case where the acquired company can't grow organically ...
We have been long Jun 55 calls here after rolling up the post earnings win, and we have be...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.